Home » Headlines » Currently Reading:

Morning Headlines 10/31/19

October 30, 2019 Headlines No Comments

Surescripts hit with another e-prescribing monopoly lawsuit

Falconer Pharmacy in New York files a class-action lawsuit against Surescripts, alleging that the company, along with co-conspirators McKesson and Allscripts, has forced the pharmacy to use its e-prescribing network to avoid higher rates as a “non-loyal customer.”

Premier Inc. Acquires Medpricer to Optimize Savings in Purchased Services

Group purchasing organization and consulting firm Premier Inc. acquires Medpricer, a developer of purchased services management technology, for $35 million.

Parthenon invests in MRO

Private equity firm Parthenon acquires an ownership stake in release-of-information vendor MRO.

Huron Announces Partnership with Medically Home Group, Inc.

Huron joins virtual hospital company Medically Home Group’s Series B round of funding, and becomes the exclusive implementation partner for its hospital-to-home care services.

Outcome Health Reaches Favorable Resolution with the DOJ Related to Past Misconduct by Former Employees

Digital patient education tech vendor Outcome Health avoids prosecution by the DoJ for the past misconduct of former employees by agreeing to pay $70 million in restitution to customers.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Challenger exploded on lift-off when the O-rings failed. Columbia disintegrated on reentry after one of the heat shield tiles were…

  2. RE the AI GLP1 company, Washington Post has an article today by someone who used one of those compounded products,…

  3. Re: A chief health AI transformation officer (CHAITO) I predict a position evolution along the following lines. "We have too…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.